# Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension

> **NCT00372827** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 245 (—)

## Conditions studied

- Primary Open-angle Glaucoma
- Ocular Hypertension
- Pigment Dispersion Glaucoma

## Interventions

- **DRUG:** Brinzolamide 1% added to Travoprost 0.004%

## Key facts

- **NCT ID:** NCT00372827
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2006-01
- **Final completion:** 2006-01
- **Target enrollment:** 245 (—)
- **Last updated:** 2016-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00372827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00372827, "Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00372827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*